A single course of remission reinduction chemotherapy for acute myelogenous leukemia relapsing after allogeneic bone marrow transplantation is complicated by graft-versus-host disease and followed by sustained complete remission
暂无分享,去创建一个
R. Decorte | C. Wolf‐peeters | J. Cassiman | P. Vandenberghe | M. Boogaerts | P. Zachée | G. Verhoef | H. Demuynck | M. Emonds
[1] A Ferrant,et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.
[2] E D Thomas,et al. 1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.
[3] P. Goulder,et al. Transfusion‐associated graft‐versus‐host disease: report of an occurrence following the administration of irradiated blood , 1993, Transfusion.
[4] J. Dover,et al. Graft-versus-Host Disease Associated with Transfusion of Blood from Unrelated HLA-Homozygous Donors , 1993 .
[5] J. Ferrara,et al. Cytokine dysregulation and acute graft-versus-host disease. , 1992, Blood.
[6] R. Decorte,et al. Evaluation of the ALF DNA sequencer for high‐speed sizing of short tandem repeat alleles , 1996, Electrophoresis.
[7] J. Antin. Graft-versus-leukemia: no longer an epiphenomenon. , 1993, Blood.
[8] R. Billingham. The biology of graft-versus-host reactions. , 1966, Harvey lectures.